Stocks/INKT

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

INKT

↓ PDF (Pro)
MiNK Therapeutics Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$11.56
+0.21%today
MKT CAP
$58M
-12.5% · 1Y
Earnings History
-14.8%
-93.9%
+24.0%
+17.6%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$11.56
Low
$35.00
Analyst Mean
$39.00
High
$43.00
2 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-3.2x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership60.5%
Institutional Ownership3.1%
Short % of Float4.79%
Days to Cover1.4d
1 Week+5.7%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Top Holders
HolderType% HeldValueΔ SharesAs of
Vanguard Group Incinstitution1.36%$0.00B+102.85%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fundfund0.99%$0.00B+228.82%2025-12-31
DRW Securities, LLCinstitution0.52%$0.00B+100.00%2025-12-31
Longbow Finance Sainstitution0.33%$0.00B+0.00%2025-12-31
Geode Capital Management, LLCinstitution0.29%$0.00B+11.25%2025-12-31
Renaissance Technologies, LLCinstitution0.21%$0.00B-28.77%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fundfund0.20%$0.00B+0.00%2025-12-31
UBS Group AGinstitution0.19%$0.00B+69.05%2025-12-31
Fidelity Concord Street Trust-Fidelity Extended Market Index Fundfund0.13%$0.00B-0.36%2026-02-28
Blackrock Inc.institution0.12%$0.00B-1.51%2025-12-31
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fundfund0.04%$0.00B+0.00%2026-02-28
Fidelity Concord Street Trust-Fidelity Total Market Index Fundfund0.04%$0.00B+0.00%2026-02-28
Fidelity Concord Street Trust-Fidelity Series Total Market Index Fundfund0.03%$0.00B+0.00%2026-02-28
Citigroup Inc.institution0.01%$0.00B+100.00%2025-12-31
Bank of America Corporationinstitution0.01%$0.00B+0.00%2025-12-31
Tower Research Capital LLC (TRC)institution0.01%$0.00B-68.14%2025-12-31
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total5
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for INKT.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.